Navigation Links
MEI Pharma CEO To Present At Wedbush Life Sciences Management Access Conference
Date:8/1/2013

-143 and ME-344. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.


'/>"/>
SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  CVS Caremark (NYSE: CVS ... clinical affiliation with MedStar Health, a leading health care ... and the Washington, DC , ... care services for patients. Through this clinical affiliation, MedStar ... support, medication counseling, chronic disease monitoring and wellness programs ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
(Date:8/27/2014)... Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... H. Mackaness is scheduled to make an investor presentation ... 2:55 p.m. Eastern Time on Wednesday, September 3, in New ... the investor presentation will be available in the Investors section ... About IRIDEX IRIDEX Corporation was founded in ...
Breaking Medicine Technology:CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical ... President and Chief Executive Officer (CEO).  Thomas Beck, M.D., ... resume his role as Chief Medical Officer of the ... cream, is concluding Phase 3 clinical trials to support ...
... N.C., Nov. 17, 2010 Patients with Chronic Obstructive ... disease as both a burden they must deal with ... recent in-home research conducted by GlaxoSmithKline.  Patients participating in ... combination of factors including loss of energy, loss of ...
Cached Medicine Technology:Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 2Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 3COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 2COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 3
(Date:8/27/2014)... 27, 2014 China’s regulatory framework ... of dramatic changes. The country’s new leaders have ... of medical equipment are far from being alongside ... past 30 years. Chinese state council issued the ... Medical Devices” to try to completely change such ...
(Date:8/27/2014)... Toronto, Ontario (PRWEB) August 27, 2014 When ... getting a call from his mother; one that he credits ... ever received. His mom had news that she could set ... camp supporting people with disabilities. Jagger took that job, and ... the disabled. Throughout these past two decades, he also worked ...
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- A new study ... effective treatment for seniors with sleep apnea. CPAP ... sleep apnea, a condition in which the airway relaxes ... sleep that leads to daytime drowsiness. ... of air through a patient,s nose via a mask ...
(Date:8/27/2014)... parents shapes many aspects of our lives. But in ... is set during development, but can be altered by ... of our parents and grandparents. , The epigenome consists ... that determine whether genes are expressed or silenced. , ... health, but also that it may be possible to ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president ... the NPSF Lucian Leape Institute, is among the 100 Most ... of Modern Healthcare magazine. Also on the list are NPSF ... MBA; NPSF Lucian Leape Institute members Carolyn Clancy, MD; ... member of both the Institute and the NPSF Board of ...
Breaking Medicine News(10 mins):Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 2Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3
... BMR, TORONTO, March 12 /PRNewswire-FirstCall/ - ... in the development and,commercialization of cancer therapies, ... year operational and financial results., Operational ... 31, 2007, the Company achieved the,following steps ...
... INDIANAPOLIS and LONDON, March 12 Today Eli,Lilly ... to the World,Health Organization (WHO) for scaling up ... (MDR-TB) programs., The grant covers four activities, ... to developing countries that the Global,Fund to Fight ...
... Rosa and Santa Rosa Memorial, Hospital to ... make Memorial responsive to its workforce ... In the wake of,news about Sonoma County,s healthcare ... already engaged in a multi-year effort,to win an effective ...
... Brazil, March 11 Amilpar,(BOVESPA: AMIL3, Bloomberg: AMIL3 ... in Brazil, announced today its consolidated,results for the ... The Company,s,operational and financial information is presented on ... with Brazilian Corporate Law and the,Accounts Chart of ...
... blood test that would show whether an antidepressant is ... say they,ve discovered a biomarker for depression that could ... a particular antidepressant is making headway against the disease. ... for depression," said study co-author Mark Rasenick, director of ...
... Speaks on Behalf of People with ... Diabetes During Congressional Briefing, WASHINGTON, March 11 ... of Congress to support,a bill that will develop a national ... was joined today at a briefing on Capitol,Hill by a ...
Cached Medicine News:Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 2Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 3Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 4Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 5Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 6Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 7Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 8Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 9Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 10Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 2Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 3Health News:Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System 2Health News:Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007 2Health News:Scientists Spot Biochemical Sign of Depression 2Health News:Scientists Spot Biochemical Sign of Depression 3Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 2Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 3
... Medical Delta valve is designed to ... and maintain intraventricular pressure (IVP) within ... patient position. The normally closed Delta ... positive ventricular pressure. Working with the ...
... is an adjustable flow control valve in ... can be changed non-invasively by the caregiver. ... cerebrospinal fluid (CSF) and maintain intraventricular pressure ... of patient position. The normally closed Delta ...
...
... try Cadwell paired disc electrodes. They combine ... contacts are 10 mm (0.4 in) in ... steel with a locator pin on the ... and available in twisted pairs. Shielded paired ...
Medicine Products: